LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

Home・Aandelen Lijst・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Gesloten

SectorGezondheidszorg

29.4 -1.57

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

29.24

Max

30.8

Belangrijke statistieken
By Trading Economics
Inkomsten	-14M -81M
Verkoop	75K 75K
EPS	-1.22
Winstmarge	-108,422.667
Werknemers	198
EBITDA	-7.8M -81M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+75.79% upside

Dividenden
By Dow Jones
Volgende Winsten	6 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	430M 2B
Vorige openingsprijs	30.97
Vorige sluitingsprijs	29.4

Nieuwssentiment

By Acuity

50%

153 / 351 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

18.91 / 20.63 Steun & Weerstand

Celldex Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

12 mrt 2026, 23:12 UTC

Populaire aandelen

Stocks to Watch: Adobe, Mission Produce, Buzzfeed, Ulta

12 mrt 2026, 22:15 UTC

Winsten

Wheaton Precious Metals Logs Higher 4Q Net Income, Boosts Dividend 18%

12 mrt 2026, 21:42 UTC

Belangrijke Nieuwsgebeurtenissen

Stryker Says Cyberattack Disruption Is Continuing

12 mrt 2026, 21:29 UTC

Belangrijke Nieuwsgebeurtenissen

Correction to War in Iran May Upend Brazil Central Bank's Plans Article

12 mrt 2026, 21:27 UTC

Winsten

Adobe CEO to Depart as AI Boosts Sales -- Update

12 mrt 2026, 20:46 UTC

Winsten

Adobe Posts Higher Sales With CEO Set to Depart

12 mrt 2026, 20:21 UTC

Belangrijke Nieuwsgebeurtenissen

Soybean Futures Higher on Instability in Iran --Daily Grain Highlights

12 mrt 2026, 23:57 UTC

Marktinformatie

Gold Edges Higher Amid Ongoing Middle East Conflict -- Market Talk

12 mrt 2026, 23:38 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

12 mrt 2026, 23:38 UTC

Marktinformatie

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

12 mrt 2026, 22:13 UTC

Winsten

Orient Overseas: Tariff Measures, Trade Tensions Weighed on Results >0316.HK

12 mrt 2026, 22:13 UTC

Winsten

Orient Overseas: Middle East Situation Have Added to Future Uncertainity >0316.HK

12 mrt 2026, 22:13 UTC

Winsten

Orient Overseas: Charter Market Remains Exceptionally Tight With Vessels in Short Supply >0316.HK

12 mrt 2026, 22:13 UTC

Winsten

Orient Overseas 2025 Rev $9.72B Vs. $10.70B >0316.HK

12 mrt 2026, 22:13 UTC

Winsten

Orient Overseas 2025 Net $1.51B Vs. Net $2.58 >0316.HK

12 mrt 2026, 22:13 UTC

Marktinformatie

Winsten

Global Equities Roundup: Market Talk

12 mrt 2026, 22:13 UTC

Marktinformatie

Winsten

Adobe Says Customers Want to Try AI Products for Free First -- Market Talk

12 mrt 2026, 21:16 UTC

Acquisities, Fusies, Overnames

Alexander & Baldwin: JV Formed by Affil of MW Group and Funds Affiliated With Blackstone and DivcoWest Completed Acquisition of All Outstanding A&B Common Shrs >ALEX

12 mrt 2026, 21:04 UTC

Winsten

Adobe Earnings Beat Is Overshadowed by CEO Departure. The Stock Is Sliding. -- Barrons.com

12 mrt 2026, 21:02 UTC

Winsten

Wheaton Precious Metals 4Q Adj EPS $1.22 >WPM

12 mrt 2026, 21:02 UTC

Winsten

Wheaton Precious Metals 4Q Sales $865M >WPM

12 mrt 2026, 21:02 UTC

Winsten

Wheaton Precious Metals 4Q Net $558.3M >WPM

12 mrt 2026, 21:02 UTC

Winsten

Wheaton Precious Metals 4Q EPS $1.23 >WPM

12 mrt 2026, 20:57 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

No Need For Canada Rate Increases Amid Jump in Bond Yields -- Market Talk

12 mrt 2026, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

12 mrt 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

12 mrt 2026, 20:15 UTC

Acquisities, Fusies, Overnames

Eaton Completes Acquisition Of Leading Liquid-cooling Solutions Provider Boyd Thermal, Creating An Industry-leading Grid-to-chip Solution For Data Centers >ETN

12 mrt 2026, 20:10 UTC

Winsten

Adobe Sees 2Q Rev $6.43B-$6.48B >ADBE

12 mrt 2026, 20:05 UTC

Winsten

Adobe 1Q Rev $6.4B >ADBE

12 mrt 2026, 20:05 UTC

Winsten

Adobe Sees 2Q Adj EPS $5.80-Adj EPS $5.85 >ADBE

Peer Vergelijking

Prijswijziging

Celldex Therapeutics Inc Prognose

Koersdoel

By TipRanks

75.79% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 54.9 USD 75.79%

Hoogste 90 USD

Laagste 24 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Celldex Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

Buy

Hold

Sell

Gebaseerd op 11 analisten die aandelenratings hebben gegeven aan Celldex Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

18.91 / 20.63Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

153 / 351 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.